Search

everythinglearnresearchcommunity

for

Search:↓

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Using tissue expanders and hyaluronidase in scalp reduction surgery allows for more scalp removal and easier surgery.

AGA increased yearly, type I most common, and family history and seborrheic dermatitis often linked.

Balding people may have higher heart disease risk.

Secondary aesthetic surgeries for gender reassignment are generally satisfying and advance overall aesthetic surgery techniques, but psychological support is important.

Chinese men have lower AGA rates than Caucasians, with type III vertex most common; family history is important.

Eyebrow loss has many causes and requires accurate diagnosis for proper treatment.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Air pollution worsens skin diseases and aging by causing inflammation and oxidative stress.

Some alternative vitiligo treatments show promise, but none are as effective as psoralens and UVA.

Pregnancy can cause symptoms similar to rheumatic diseases, making diagnosis difficult, and affects various body systems, requiring careful distinction between normal changes and serious conditions.

Cromolyn sodium's effectiveness for treating asthma in children under 2 is unclear, possibly more beneficial for older children, and further research is needed.

Androgenetic Alopecia (AGA) greatly lowers quality of life, causing stress and low self-esteem, with those seeking treatment experiencing more impairment.

People with androgenetic alopecia are more likely to have metabolic syndrome.

A 60-year-old man with a long-term balding condition also developed a rare hair loss condition usually seen in postmenopausal women.

Hair loss in women often doesn't follow a pattern, isn't linked to age, may be genetic, and can be related to thyroid issues or other health factors.

Frontal fibrosing alopecia in families shows similar signs to individual cases and may have a genetic link.

Low iron levels may be linked to hair loss in women with chronic telogen effluvium.

Finasteride and low-level laser therapy are similarly effective for frontal pattern hair loss.

Men with Frontal fibrosing alopecia typically lose hair on the front scalp and sometimes on sideburns and upper lip, with treatments showing varied success.

Two trichoscopic patterns found in hair loss: diffuse fibrotic and androgenetic alopecia, affecting treatment choice and regrowth chances.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Frontal fibrosing alopecia in Brazil mostly affects postmenopausal women, often linked with hypothyroidism and eyebrow hair loss.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Infrared thermography, especially with dermoscopy, improves accuracy in diagnosing active hair loss due to inflammation.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Mesotherapy with dutasteride improves hair growth and reduces symptoms in frontal fibrosing alopecia.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.